Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Dose Effects on Fibrin Network in Type 1 Diabetes
NCT01397513Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Mar 2006
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in type 1 diabetes mellitus (T1D), sponsored by Karolinska Institutet. Started Mar 2006; status: completed.
02
Drugs
aspirin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01397513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01397513.